![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marco Onofrj, Fausta Ciccocioppo, Sara Varanese, Antonio di Muzio, Menotti Calvani, Santina Chiechio, Maurizio Osio & Astrid Thomas. (2013) Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond. Expert Review of Neurotherapeutics 13:8, pages 925-936.
Read now
Read now
Cesare Mancuso, Timothy E Bates, D Allan Butterfield, Stella Calafato, Carolin Cornelius, Antonino De Lorenzo, Albena T Dinkova Kostova & Vittorio Calabrese. (2007) Natural antioxidants in Alzheimer's disease. Expert Opinion on Investigational Drugs 16:12, pages 1921-1931.
Read now
Read now
Articles from other publishers (57)
Hussein N. Yassine, Wade Self, Bilal E. Kerman, Giulia Santoni, NandaKumar Navalpur Shanmugam, Laila Abdullah, Lesley R. Golden, Alfred N. Fonteh, Michael G. Harrington, Johannes Gräff, Gary E. Gibson, Raj Kalaria, Jose A. Luchsinger, Howard H. Feldman, Russell H. Swerdlow, Lance A. Johnson, Benedict C. Albensi, Berislav V. Zlokovic, Rudolph Tanzi, Stephen Cunnane, Cécilia Samieri, Nikolaos Scarmeas & Gene L. Bowman. (2022) Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias. Alzheimer's & Dementia 19:3, pages 1041-1066.
Crossref
Crossref
Maija Dambrova, Marina Makrecka-Kuka, Janis Kuka, Reinis Vilskersts, Didi Nordberg, Misty M. Attwood, Stefan Smesny, Zumrut Duygu Sen, An Chi Guo, Eponine Oler, Siyang Tian, Jiamin Zheng, David S. Wishart, Edgars Liepinsh & Helgi B. Schiöth. (2022) Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacological Reviews 74:3, pages 506-551.
Crossref
Crossref
Sandra I. Mota, Inês Pita, Rodolfo Águas, Slah Tagorti, Ashraf Virmani, Frederico C. Pereira & A. Cristina Rego. (2021) Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer’s disease in vitro model. Archives of Toxicology 95:8, pages 2769-2784.
Crossref
Crossref
Sergej M. Ostojic. 2021. Clinical Bioenergetics. Clinical Bioenergetics
431
450
.
Manuela Pennisi, Giuseppe Lanza, Mariagiovanna Cantone, Emanuele D’Amico, Francesco Fisicaro, Valentina Puglisi, Luisa Vinciguerra, Rita Bella, Enzo Vicari & Giulia Malaguarnera. (2020) Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. Nutrients 12:5, pages 1389.
Crossref
Crossref
Sina Radfar & Seyyed M. Ghoreishi. (2018) Experimental extraction of L-Carnitine from oyster mushroom with supercritical carbon dioxide and methanol as co-solvent: Modeling and optimization. The Journal of Supercritical Fluids 140, pages 207-217.
Crossref
Crossref
Geraldine Goodison, Kathie Overeem, Veronica de Monte & Dan Siskind. (2016)
Mania associated with self-prescribed acetyl-
l
-carnitine in a man with bipolar I disorder
. Australasian Psychiatry 25:1, pages 13-14.
Crossref
Crossref
Cole Vonder Haar, Todd C. Peterson, Kris M. Martens & Michael R. Hoane. (2016) Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies. Brain Research 1640, pages 114-129.
Crossref
Crossref
Knut Hagen, Eiliv Brenner, Mattias Linde, Gøril Bruvik Gravdahl, Erling Andreas Tronvik, Morten Engstrøm, Ursula Sonnewald, Grethe Helde, Lars Jacob Stovner & Trond Sand. (2015) Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study. Cephalalgia 35:11, pages 987-995.
Crossref
Crossref
Heather M. Yonutas, Elizabeth Head & Patrick G. Sullivan. 2015. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults
71
83
.
Gregory E. Bigford & Gianluca Del Rossi. (2014) Supplemental Substances Derived from Foods as Adjunctive Therapeutic Agents for Treatment of Neurodegenerative Diseases and Disorders. Advances in Nutrition 5:4, pages 394-403.
Crossref
Crossref
Hyeyun KimDo Young YoonDoo Yong ParkHyun Jeong Han. (2014) Vivid Dreaming after Acetyl-L-Carnitine Administration: A Report of Two Cases. Journal of the Korean Geriatrics Society 18:3, pages 162.
Crossref
Crossref
Ikumi Tamai. (2012) Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21). Biopharmaceutics & Drug Disposition 34:1, pages 29-44.
Crossref
Crossref
Tilman Grune, Betul Catalgol & Tobias Jung. 2012. Protein Oxidation and Aging. Protein Oxidation and Aging
295
415
.
Lillian C. Becker, Wilma F. Bergfeld, Donald V. Belsito, Ronald A. Hill, Curtis D. Klaassen, Daniel Liebler, James G. MarksJrJr, Ronald C. Shank, Thomas J. Slaga, Paul W. Snyder & F. Alan Andersen. (2013) Safety Assessment of Trimoniums as Used in Cosmetics. International Journal of Toxicology 31:6_suppl, pages 296S-341S.
Crossref
Crossref
S.P. Patel, P.G. Sullivan, T.S. Lyttle, D.S.K. Magnuson & A.G. Rabchevsky. (2012) Acetyl-l-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. Neuroscience 210, pages 296-307.
Crossref
Crossref
Amy L.S. Dowling & Elizabeth Head. (2012) Antioxidants in the canine model of human aging. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:5, pages 685-689.
Crossref
Crossref
Cesare Mancuso, Raffaella Siciliano, Eugenio Barone & Paolo Preziosi. (2012) Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:5, pages 616-624.
Crossref
Crossref
Alexander G. Rabchevsky, Samir P. Patel & Joe E. Springer. (2011) Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?. Pharmacology & Therapeutics 132:1, pages 15-29.
Crossref
Crossref
. (2011) Scientific Opinion on the substantiation of health claims related to acetyl-L-carnitine and contribution to normal cognitive function (ID 1432) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 9:6, pages 2200.
Crossref
Crossref
Elizabeth Head & Steven C. Zicker. 2011. Studies on Veterinary Medicine. Studies on Veterinary Medicine
101
111
.
Samir P. Patel, Patrick G. Sullivan, Travis S. Lyttle & Alexander G. Rabchevsky. (2010) Acetyl-l-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. Journal of Neurochemistry, pages no-no.
Crossref
Crossref
Elizabeth Head. 2010. Aging and Age-Related Disorders. Aging and Age-Related Disorders
381
397
.
Vittorio Calabrese, Carolin Cornelius, Cesare Mancuso, Riccardo Lentile, A.M. Giuffrida Stella & D. Allan Butterfield. 2010. Free Radicals and Antioxidant Protocols. Free Radicals and Antioxidant Protocols
285
308
.
Elizabeth Head. (2008) Oxidative Damage and Cognitive Dysfunction: Antioxidant Treatments to Promote Healthy Brain Aging. Neurochemical Research 34:4, pages 670-678.
Crossref
Crossref
James Suchy, Amy Chan & Thomas B. Shea. (2009) Dietary supplementation with a combination of α-lipoic acid, acetyl-l-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutrition Research 29:1, pages 70-74.
Crossref
Crossref
Christiane Richter-LandsbergVittorio Calabrese, Giovanni Pennisi, Menotti Calvani, D. Allan Butterfield, Cesare Mancuso & Anna Maria Giufrrida Stella. 2009. Heat Shock Proteins in Neural Cells. Heat Shock Proteins in Neural Cells
39
52
.
Vittorio Calabrese, Carolin Cornelius, Cesare Mancuso, Giovanni Pennisi, Stella Calafato, Francesco Bellia, Timothy E. Bates, Anna Maria Giuffrida Stella, Tony Schapira, Albena T. Dinkova Kostova & Enrico Rizzarelli. (2008) Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity. Neurochemical Research 33:12, pages 2444-2471.
Crossref
Crossref
Vittorio Calabrese, Riccardo Ientile, Carolin Cornelius, Marina Scalia, Maria Cambria, Bernardo Ventimiglia, Giovanni Pennisi, Cesare Mancuso & D Allan Butterfi eld. 2008. Dietary Modulation of Cell Signaling Pathways. Dietary Modulation of Cell Signaling Pathways.
Michele Malaguarnera, Maria Pia Gargante, Erika Cristaldi, Valentina Colonna, Masa Messano, Aleardo Koverech, Sergio Neri, Marco Vacante, Lisa Cammalleri & Massimo Motta. (2008) Acetyl l-carnitine (ALC) treatment in elderly patients with fatigue. Archives of Gerontology and Geriatrics 46:2, pages 181-190.
Crossref
Crossref
Vincenzo Giordano, Gianfranco Peluso, Maurizio Iannuccelli, Paola Benatti, Raffaella Nicolai & Menotti Calvani. (2006) Systemic and Brain Metabolic Dysfunction as a New Paradigm for Approaching Alzheimer’s Dementia. Neurochemical Research 32:4-5, pages 555-567.
Crossref
Crossref
Ba X. Hoang, D. Graeme Shaw, Phuong Pham & Stephen Levine. (2007) Restoration of cellular energetic balance with l-carnitine in the neuro-bioenergetic approach for cancer prevention and treatment. Medical Hypotheses 69:2, pages 262-272.
Crossref
Crossref
Giovanni B. Frisoni, Elisa Canu, Cristina Geroldi, Orazio Zanetti & Valeria Zacchi. (2006) Drug prescription in mild cognitive impairment: the physicians' perspective in Italy. International Journal of Geriatric Psychiatry 21:11, pages 1071-1077.
Crossref
Crossref
Masato Inazu, Hiroshi Takeda, Katsuyuki Maehara, Kyoji Miyashita, Akio Tomoda & Teruhiko Matsumiya. (2006) Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. Journal of Neurochemistry 97:2, pages 424-434.
Crossref
Crossref
M. Manders, L. C. P. G. M. de Groot, W. A. van Staveren, W. Wouters-Wesseling, A. J. M. J. Mulders, J. M. G. A. Schols & W. H. L. Hoefnagels. (2004) Effectiveness of Nutritional Supplements on Cognitive Functioning in Elderly Persons: A Systematic Review. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:10, pages M1041-M1049.
Crossref
Crossref
Mark A. McDaniel, Steven F. Maier & Gilles O. Einstein. (2003) ?Brain-specific? nutrients: a memory cure?. Nutrition 19:11-12, pages 957-975.
Crossref
Crossref
Sheila A Hudson & Naji Tabet. (2003) Acetyl-l-carnitine for dementia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bruce J Diamond, Susan K Johnson, Kathleen Torsney, Jennifer Morodan, Brian J Prokop, Dana Davidek & Patricia Kramer. (2003) Complementary and Alternative Medicines in the Treatment of Dementia. Drugs & Aging 20:13, pages 981-998.
Crossref
Crossref
P. Clayton. 2003. Performance Functional Foods. Performance Functional Foods
21
37
.
Lon S. Schneider, Nawab Qizilbash, Mary Sano, Fadi Massoud, Jeffrey Kaye, Jason T. Olin, Knut Laake, Anne Rita Øksengaard, Barry S. Oken, Kristine Yaffe, Kentaro Hashimoto, Jesus López‐Arrieta, John C. S. Breitner, Leon Flicker, Kenneth Rockwood & Josẽ Luísrodríquez‐Martin. 2003. Evidence‐based Dementia Practice. Evidence‐based Dementia Practice
467
588
.
Mark A. McDaniel, Steven F. Maier & Gilles O. Einstein. (2017) “Brain-Specific” Nutrients: A Memory Cure?. Psychological Science in the Public Interest 3:1, pages 12-38.
Crossref
Crossref
J.C. de la Torre. (2002) Alzheimer Disease as a Vascular Disorder. Stroke 33:4, pages 1152-1162.
Crossref
Crossref
Jiankang Liu, Elizabeth Head, Afshin M. Gharib, Wenjun Yuan, Russell T. Ingersoll, Tory M. Hagen, Carl W. Cotman & Bruce N. Ames. (2002)
Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-
l
-carnitine and/or
R
-α-lipoic acid
. Proceedings of the National Academy of Sciences 99:4, pages 2356-2361.
Crossref
Crossref
Yasuto Kido, Ikumi Tamai, Aki Ohnari, Yoshimichi Sai, Toru Kagami, Jun‐ichi Nezu, Hiroko Nikaido, Noriyoshi Hashimoto, Masahide Asano & Akira Tsuji. (2008)
Functional relevance of carnitine transporter OCTN2 to brain distribution of
l
‐carnitine and acetyl‐
l
‐carnitine across the blood–brain barrier
. Journal of Neurochemistry 79:5, pages 959-969.
Crossref
Crossref
Chris D. Meletis & Ben Bramwell. (2001) Natural Therapies to Preserve and Enhance Cognition and Memory. Alternative and Complementary Therapies 7:5, pages 273-276.
Crossref
Crossref
William Pryse-Phillips, Shelley Sternberg, Paula Rochon, Gary Naglie, Howard Strong & John Feightner. (2014) The Use of Medications for Cognitive Enhancement. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 28:S1, pages S108-S114.
Crossref
Crossref
G.J. Brewer. (2000) Neuronal plasticity and stressor toxicity during aging. Experimental Gerontology 35:9-10, pages 1165-1183.
Crossref
Crossref
Brian R. Ott & Norma J. Owens. (1998) Complementary and Alternative Medicines for Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology 11:4, pages 163-173.
Crossref
Crossref
Shirish V. Patel. (2016) Pharmacotherapy of Cognitive Impairment in Alzheimer's Disease: A Review. Journal of Geriatric Psychiatry and Neurology 8:2, pages 81-95.
Crossref
Crossref
Jair C. Soares & Samuel Gershon. (1994) Advances in the pharmacotherapy of Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 244:5, pages 261-271.
Crossref
Crossref
Massimo Castorina & Laura Ferraris. (1994) Acetyl-L-carnitine affects aged brain receptorial system in rodents. Life Sciences 54:17, pages 1205-1214.
Crossref
Crossref
D. Allan Butterfield & Anuradha Rangachari. (1993) Acetylcarnitine increases membrane cytoskeletal protein-protein interactions. Life Sciences 52:3, pages 297-303.
Crossref
Crossref
D. Allan Butterfield, A. Rangachari, D. T. Isbell & S. A. Umhauer. (1992) Spin labeling studies of the interactions of potentially useful therapeutic agents for the treatment of Alzheimer’s disease with cytoskeletal proteins in erythrocyte ghosts and brain synaptosomal membranes. Applied Magnetic Resonance 3:5, pages 883-897.
Crossref
Crossref
A. CARTA & M. CALVANI. (1991) Acetyl-l-Carnitine: A Drug Able to Slow the Progress of Alzheimer's Disease?. Annals of the New York Academy of Sciences 640:1, pages 228-232.
Crossref
Crossref
G. A. Livingston, K. B. Sax, Z. McClenahan, E. Blumenthal, K. Foley, J. Willison, A. H. Mann & I. M. James. (2004) Acetyl‐L‐Carnitine in dementia. International Journal of Geriatric Psychiatry 6:12, pages 853-860.
Crossref
Crossref
Chung S. Kim & Charles R. Roe. (1991) Kinetic analysis ofl-carnitine uptake by the choroid plexus. Brain Research 554:1-2, pages 193-197.
Crossref
Crossref
Michael Davidson & Robert G. Stem. (1991) The Treatment of Cognitive Impairment in Alzheimer’s Disease: Beyond the Cholinergic Approach. Psychiatric Clinics of North America 14:2, pages 461-482.
Crossref
Crossref